SymbolSTAA
NameSTAAR SURGICAL CO
SectorHEALTH CARE
RegionNorth America
IndustryOphthalmic Goods
Address1911 WALKER AVE, MONROVIA, CA 91016
Telephone6263037902
Fax
Email
Websitehttps://www.staar.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0000718937
Description

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.

Additional info from NASDAQ:
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.

2026-08-18 20:03

ANDREWS DEBORAH J 🟡 adjusted position in 50.9K shares (4 derivative) of STAAR SURGICAL CO (STAA) at $26.18 ($1.1M) Transaction Date: Aug 14, 2026 | Filing ID: 000011

Read more
2026-08-18 20:03

Foust Warren 🟡 adjusted position in 372.8K shares (7 derivative) of STAAR SURGICAL CO (STAA) at $26.18 ($8.9M) Transaction Date: Aug 14, 2026 | Filing ID: 000014

Read more
2026-08-18 20:03

Michna Magda 🟡 adjusted position in 9.8K shares (2 derivative) of STAAR SURGICAL CO (STAA) at $26.18 Transaction Date: Aug 14, 2026 | Filing ID: 000011

Read more
2026-08-14 11:05

New Form SCHEDULE 13G/A - STAAR SURGICAL CO <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001013594-26-000899 <b>Size:</b> 14 KB

Read more
2026-08-12 20:04

(30% Negative) STAAR SURGICAL CO (STAA) Reports Q3 2026 Financial Results

Read more
2026-08-12 20:01

STAAR Surgical Reports Second Quarter 2026 Results

Read more
2026-08-04 20:05

STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer

Read more
2026-08-04 20:01

STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026

Read more
2026-07-16 20:01

STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026

Read more
2026-06-24 13:37

New Form S-8 - STAAR SURGICAL CO <b>Filed:</b> 2026-06-24 <b>AccNo:</b> 0000718937-26-000032 <b>Size:</b> 760 KB

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT07790965 Study of a Phakic Implantable Collamer Lens (ICL) Na Myopia Not_Yet_Recruiting 2026-11-01 2027-05-01 ClinicalTrials.gov
NCT07791381 Study of an Implantable Collamer Lens (ICL) Na Myopia Not_Yet_Recruiting 2026-11-01 2027-05-01 ClinicalTrials.gov
Total clinical trials: 2
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Implantable collamer lens (ICL) Other Approved Myopia NOT_YET_RECRUITING NCT07791381
Phakic Implantable Collamer Lens (ICL) Other Approved Myopia NOT_YET_RECRUITING NCT07790965
Total products: 2